.

The wingspan stent system for the treatment of intracranial atherosclerotic stenoses.

LAUR Repository

Show simple item record

dc.contributor.author Lee, Doek Hee
dc.contributor.author Morsi, Hesham
dc.contributor.author Daza, Orlando Diaz
dc.contributor.author Arat, Anit
dc.date.accessioned 2019-07-12T09:03:04Z
dc.date.available 2019-07-12T09:03:04Z
dc.date.copyright 2009 en_US
dc.identifier.issn 2233-6273 en_US
dc.identifier.uri http://hdl.handle.net/10725/11048
dc.description.abstract PURPOSE A self-expandable nitinol stent (WingSpan stent; Boston Scientific Corp.) was introduced for the treatment of intracranial stenoses. The purpose of this study is to present our initial experience with the WingSpan stent for the treatment of atherosclerotic stenoses of the cerebral arteries. MATERIALS AND METHODS Consecutive 37 patients (mean age: 66.8 years, 17 men and 20 women) with symptomatic severe stenoses (>50%) of various anatomic sites were treated with WingSpan stent (BSC). Treatment result was evaluated in terms of technical success rate, intra-procedural event, and clinical course. Neurological morbidity and mortality rates were obtained. Arterial patency was evaluated with the 6 month follow-up angiography. Restenosis over 50% was regarded as significant. RESULTS The technical success rate was 97.3% (36/37). Flow-limiting vasospasm or dissection after balloon angioplasty (n=3), misplacement of the stent (n=3), and acute in-stent thrombosis (n=1) were occurred. The initial stenosis before the procedure (71.7%) was improved after balloon angioplasty (39.8%) and after subsequent stent placement (20.0%). There were four neurological events during periprocedural period. Those were two TIA, one minor stroke, and one major stroke. The periprocedural morbidity rate was 5.4%. One mortality was the case of progression of previous brainstem infarction. Six-month-follow-up angiography was available in 16 patients and in-stent restenosis was noted in 7 (43.8%). CONCLUSION WingSpan stents could be delivered to the target lesions without difficulty. However, the system showed technical problems such as misplacement. Restenosis seemed not infrequent on our limited follow-up observations. en_US
dc.language.iso en en_US
dc.title The wingspan stent system for the treatment of intracranial atherosclerotic stenoses. en_US
dc.type Article en_US
dc.description.version Published en_US
dc.title.subtitle a single center experience en_US
dc.author.school SOM en_US
dc.author.idnumber 201700518 en_US
dc.author.department N/A en_US
dc.description.embargo N/A en_US
dc.relation.journal Neurointervention en_US
dc.journal.volume 4 en_US
dc.journal.issue 2 en_US
dc.article.pages 87-93 en_US
dc.keywords Arterial stenosis en_US
dc.keywords Stroke en_US
dc.keywords Stent en_US
dc.keywords Angioplasty en_US
dc.identifier.ctation Lee, D. H., Morsi, H., Diaz Daza, O., Arat, A., & Mawad, M. E. (2009). The WingSpan Stent System for the Treatment of Intracranial Atherosclerotic Stenoses: A Single Center Experience. Neurointervention, 4(2), 87-93. en_US
dc.author.email michel.mawad@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url https://neurointervention.org/journal/view.php?number=27 en_US
dc.author.affiliation Lebanese American University en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search LAUR


Advanced Search

Browse

My Account